You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 2
  • S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial

Article metrics

Article menu

Download PDFPDF

Invited Speaker Presentation
S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial

 

Online download statistics by month:

Online download statistics by month: December 2019 to April 2025

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020032
May 2020040
Jun 2020070
Jul 2020040
Sep 2020060
Oct 2020010
Nov 2020010
Dec 2020020
Jan 2021030
Feb 2021001
Mar 2021032
Apr 2021010
Jun 2021030
Jul 2021010
Aug 2021011
Sep 2021031
Oct 2021041
Nov 2021023
Dec 2021070
Jan 2022030
Feb 2022010
Mar 2022020
Apr 2022021
May 2022061
Jun 2022040
Jul 2022050
Aug 2022065
Sep 2022030
Oct 2022011
Nov 2022041
Dec 2022040
Jan 2023030
Feb 2023010
Mar 2023010
Apr 2023001
May 2023011
Jun 2023020
Jul 2023021
Sep 2023023
Oct 2023011
Nov 2023031
Dec 2023021
Jan 2024010
Feb 2024070
Mar 20240532
Apr 2024032
May 2024030
Jun 20240130
Jul 20240102
Aug 2024030
Sep 2024091
Oct 20240124
Nov 20240191
Dec 2024091
Jan 2025096
Feb 2025021
Mar 2025031
Apr 2025041
Total023182